0
0
Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in the sixth Risperdal case to go to court in Pennsylvania.
The U.S. Judicial Panel on Multidistrict Litigation granted a coordinated docket for more than 100 lawsuits alleging the diabetes drug Invokana caused significant injuries. Cases are currently being transferred and coordinated in a multidistrict litigation in the U.S. District Court for the District of New Jersey.
C.R. Bard faces hundreds of lawsuits regarding its Inferior Vena Cava Filters (IVC filters), the first of which is scheduled to go to trial next fall. However, while the company prepares for the trial, plaintiffs around the country are filing an increasing number of Bard IVC filter lawsuits.
In June 2015, Cook Medical only faced around 100 IVC filter lawsuits; but over the course of the next year, the number of lawsuits skyrocketed. As the year comes to a close, the company now faces more than 1,000 defective IVC filter lawsuits. The new year will see at least one of these lawsuits go to trial in the fall, and Cook Medical is likely trying to prepare for this pivotal trial.
More than 250,000 cases of breast cancer are diagnosed each year, and while medical advances have given women a better chance to fight the disease, some of the drugs used to treat breast cancer can have permanent side effects. One such drug is Taxotere, which is used in chemotherapy treatment for approximately 75% of all breast cancer patients. However, studies now show Taxotere can cause permanent hair loss, called alopecia, and patients believe the manufacturer failed to warn them of this risk.
While evidence linking common heartburn drugs to dangerous side effects has greatly increased over the past year, a new study might really cause heartburn sufferers to rethink their medication. Researchers recently analyzed data from twelve separate clinical studies to determine the effect of popular heartburn medications like Nexium and Prilosec have on the development of stomach cancer.
Since healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals settled a Risperdal case in October, other plaintiffs in the Risperdal litigation hoped the settlement would set a precedent for the remaining cases. However, the companies made it clear the October settlement does not mean they are throwing in the towel, so plaintiffs are wondering what’s next in the Risperdal litigation.
Baby Powder Cancer Plaintiffs In Delaware Seek Coordinated Docket
By Andrew Steinberg / 06 December 2016
Johnson & Johnson (J&J) has desperately tried to transfer state court baby powder lawsuits into the federal multidistrict litigation (MDL) in New Jersey where the company believes the court may be more favorable, but this hasn’t stopped new lawsuits from being filed in state courts around the country. One of the largest baby powder litigations in state court is in California where cases are being coordinated in a Los Angeles court. Other states are following suit, including Delaware where ten baby powder lawsuits are currently pending against J&J.
Third Pinnacle Hip Implant Trial Awards Over $1 Billion To Plaintiffs
By Andrew Steinberg / 05 December 2016
Johnson & Johnson (J&J) has suffered several huge multimillion-dollar trial losses this year, but the worst was yet to come. The third Pinnacle hip implant trial finished closing statements earlier this week and the jury quickly returned a verdict. J&J and its subsidiary DePuy Orthopedics were found guilty of gross negligence and the jury awarded the six plaintiffs $1.04 billion in damages.
After Vincent Karst underwent open-heart surgery in early 2015, he seemed to recover well and his life slowly returned to normal. However, he slowly began to suffer from shortness of breath, nausea, and overwhelming fatigue that eventually landed him back in the hospital.